Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 15, 2025 09:47 ET | Source: Research and Markets

Avastin (Bevacizumab) Market Research Report 2025: Epidemiology, Pipeline Analysis, Insights & Forecasts 2019-2024, 2024-2029F, 2034F

Dublin, May 15, 2025 (GLOBE NEWSWIRE) -- The "Avastin (Bevacizumab) Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" report has been added to ...
February 08, 2024 15:17 ET | Source: Spherix Global Insights

Stakes Are High for Regeneron's Eylea HD as Genentech's Vabysmo Continues to Gain Momentum, Prompting Doctors to Weigh Their Options Between Two Industry Titans, According to Spherix Global Insights

Exton, Pennsylvania, Feb. 08, 2024 (GLOBE NEWSWIRE) -- As Age-Related Macular Degeneration (AMD) Awareness Month unfolds, illuminating the visual challenges faced by millions of Americans with AMD,...
December 11, 2023 11:58 ET | Source: Research and Markets

Lung Cancer Drugs Global Market Report 2024 - Regulatory Approvals and Increased Patient Awareness and Education Propel the Market

Dublin, Dec. 11, 2023 (GLOBE NEWSWIRE) -- The "Lung Cancer Drugs Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The lung cancer drugs market size has grown...
November 24, 2023 09:33 ET | Source: Research and Markets

AVASTIN Drug Insights and Market Forecasts, 2019-2023 & 2023-2032: Focus on United States, Germany, France, Italy, Spain, United Kingdom, and Japan

Dublin, Nov. 24, 2023 (GLOBE NEWSWIRE) -- The "AVASTIN Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides comprehensive...
January 19, 2023 05:43 ET | Source: Research and Markets

Global Ovarian Cancer Drugs Market Analysis, Trends, Opportunity, and Forecasts 2017-2022 & 2023-2027: Growing Prevalence of Ovarian Cancer and Increasing R&D Activities in Development

Dublin, Jan. 19, 2023 (GLOBE NEWSWIRE) -- The "Ovarian Cancer Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Drug Class, By Tumor Type, By...
July 29, 2022 06:33 ET | Source: Research and Markets

Cervical Cancer Therapeutics Epidemiology & Pipeline Analysis Report 2022-2027: Focus on United States, China, Japan, Germany, United Kingdom, France, Italy, & Spain

Dublin, July 29, 2022 (GLOBE NEWSWIRE) -- The "Cervical Cancer Therapeutics Market - Epidemiology & Pipeline Analysis 2022-2027" report has been added to ResearchAndMarkets.com's offering. The...
February 10, 2022 04:33 ET | Source: Research and Markets

Outlook on the Glioblastoma Multiforme Global Market to 2030

Dublin, Feb. 10, 2022 (GLOBE NEWSWIRE) -- The "Glioblastoma Multiforme - Global Drug Forecast and Market Analysis to 2030" report has been added to ResearchAndMarkets.com's offering. Glioblastoma...
December 21, 2021 04:33 ET | Source: Research and Markets

Global Lung Cancer Drugs Market (2021 to 2030) - Featuring Bristol-Myers Squibb, Merck & Co and F. Hoffmann-La Roche Among Others

Dublin, Dec. 21, 2021 (GLOBE NEWSWIRE) -- The "Lung Cancer Drugs Global Market Report 2021: COVID-19 Impact and Recovery to 2030" report has been added to ResearchAndMarkets.com's offering. This...
December 21, 2021 04:18 ET | Source: Research and Markets

$8 Billion Worldwide Cervical Cancer Drugs Industry to 2030 - Identify Growth Segments for Investment

Dublin, Dec. 21, 2021 (GLOBE NEWSWIRE) -- The "Cervical Cancer Drugs Global Market Report 2021: COVID-19 Impact and Recovery to 2030" report has been added to ResearchAndMarkets.com's offering. This...
October 20, 2021 05:03 ET | Source: Research and Markets

Global Avastin (Bevacizumab) Biosimilars Market Research Report 2021: Detailed Review of the Pipeline and Affiliated Developer Landscape

Dublin, Oct. 20, 2021 (GLOBE NEWSWIRE) -- The "Avastin (Bevacizumab) Biosimilars: Focus on Approved & Launched Biosimilars, Investigational & Research Use Biosimilars,...

Next Page keyboard_arrow_right